What is Ildong Holdings Co., Ltd.'s (000230.KS) StockRank?

MoatMap's StockRank for Ildong Holdings Co., Ltd. (000230.KS) is 48/100, with a Hold signal. This is a composite score combining Quality (55), Value (71), and Momentum (13) factor ranks across MoatMap's 20,000+ stock universe.

Does Ildong Holdings Co., Ltd. have an economic moat?

Ildong Holdings Co., Ltd. (000230.KS) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Ildong Holdings Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Ildong Holdings Co., Ltd. (000230.KS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Ildong Holdings Co., Ltd. in?

Ildong Holdings Co., Ltd. (000230.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000230.KS

HOLDREMOVE

Ildong Holdings Co., Ltd. · Healthcare · South Korea · $57M · Avg Vol: $108K/d

StockRank

P/E (TTM)

6.1x

ROE

10.1%

D/E

0.5x

Dividend %

1.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Ildong Holdings is a Korean pharmaceutical holding company. It lacks the high-margin, asset-light profile of a top-tier CDMO and suffers from a complex corporate structure with low capital allocation transparency.

COMPANY DESCRIPTION

Ildong Holdings Co., Ltd. is a South Korean healthcare holding company with subsidiaries focused on pharmaceuticals, medical devices, and functional food products. The company's competitive moat is anchored by its iconic over-the-counter brands, such as the Aronamin vitamin line, alongside an expanding ethical drug pipeline. It is a prominent domestic healthcare player actively transitioning toward innovative drug discovery and specialized biopharmaceuticals.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	439.9M	415.8M	413.3M	384.8M	-4.4%
EPS	-5.90	-3.40	3.64	0.63	-82.7%
Shares	11.5M	11.5M	11.5M	11.3M	-2.2%
Debt	194.8M	211.9M	211.5M	129.9M	-12.6%
Equity	7.7M	25.4M	87.2M	109.9M	142.6%
Op CF	-48.6M	-37.6M	11.3M	17.5M	55.2%
Inv CF	-21.2M	-10.6M	14.6M	13.8M	—
Fin CF	20.6M	30.2M	-20.8M	-32.9M	—

PRICE (1Y)-31.2%

SMA 50SMA 200

$3.82

RSI (14)

35.2

52W High

$11.08

From 52W High

0.3%

SCORE BREAKDOWN

Quality

ROIC

11.0%76.4

ROE

10.1%71.9

GP/Assets

27.8%61.2

Op. Margin

6.1%57.8

FCF/Assets

-2.7%41.5

Piotroski

782.3

Int. Cover

2.3x43.5

D/E Ratio

0.53x30.6

Current Ratio

0.83x6.0

Value

P/E (TTM)

6.1x95.8

EV/EBITDA

7.9x79.1

P/FCF

—N/A

P/B

0.4x97.3

P/S

0.1x99.2

Div Yield

1.6%41.1

Momentum

52W High %

34%9.9

RS 6M

-161%0.7

SMA 50/200

0.79x13.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$57M

P/E (Forward)

—

Gross Margin

39.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000230.KS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000230.KS	Ildong Holdings Co., Ltd.(you)	$57M	48	HOLD
002720.KS	Kukje Pharma Co., Ltd.	$55M	47	HOLD
003120.KS	Ilsung Is Co., Ltd.	$91M	47	HOLD
007570.KS	Ilyang Pharmaceutical Co.,Ltd	$92M	43	HOLD
176750.KQ	DuChemBIO Co.,Ltd.	$110M	46	HOLD
054670.KQ	Daehan Nupharm Co.,Ltd.	$51M	62	HOLD
271980.KS	Jeil Pharmaceutical Co.,Ltd	$98M	55	HOLD
330350.KQ	WITHUS PHARMACEUTICAL Co.,LTD.	$73M	66	BUY
102460.KS	REYON Pharmaceutical Co., Ltd.	$118M	38	HOLD
293480.KS	Hana Pharm Co., Ltd.	$103M	61	HOLD

Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%

Ildong Holdings Co., Ltd. (000230.KS) — Stock Score Summary

Ildong Holdings Co., Ltd. (000230.KS) has a MoatMap StockRank of 48/100 based on Quality (55/100), Value (71/100), and Momentum (13/100) factor scores. The current signal is HOLD. Ildong Holdings is a Korean pharmaceutical holding company. It lacks the high-margin, asset-light profile of a top-tier CDMO and suffers from a complex corporate structure with low capital allocation transparency.

Key Financial Metrics

Price	$3.82
Market Cap	$57M
P/E (TTM)	6.11
Price/Book	0.40
Return on Equity	10.1%
Return on Invested Capital	11.0%
Debt/Equity	52.61
Gross Margin	39.0%
Operating Margin	6.1%
Revenue Growth	5.5%
Dividend Yield	1.6%
Free Cash Flow	$-15M

Ildong Holdings Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Ildong Holdings Co., Ltd.’s (000230.KS) StockRank?: MoatMap’s StockRank for Ildong Holdings Co., Ltd. (000230.KS) is 48/100, with a Hold signal. It is a composite of Quality (55), Value (71), and Momentum (13) factor ranks across MoatMap’s 20,000+ stock universe.
Does Ildong Holdings Co., Ltd. have an economic moat?: Ildong Holdings Co., Ltd. (000230.KS) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ildong Holdings Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Ildong Holdings Co., Ltd. (000230.KS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ildong Holdings Co., Ltd. in?: Ildong Holdings Co., Ltd. (000230.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).